lanabecestat
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for lanabecestat, covering 2014-07-03 to 2019-08-06. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease [Phase 2, Phase 3]